Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20896 AL 20910

The protective role of exercise against age-related neurodegeneration

Sujkowski A, Hong L, Wessells RJ, Todi SV.

Ageing Res Rev. 2022 Feb;74:101543. doi: 10.1016/j.arr.2021.101543. Epub 2021 Dec 17.

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK.

J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6.

Insight γ-Secretase: Structure, Function, and Role in Alzheimer's Disease

Mal S, Malik U, Pal D, Mishra A.

Curr Drug Targets. 2021;22(12):1376-1403. doi: 10.2174/1389450121999201230203709.

[Causes and Consequences of Genome Instability in Psychiatric and Neurodegenerative Diseases]

Iourov IY, Vorsanova SG, Kurinnaia OS, Zelenova MA, Vasin KS, Yurov YB.

Mol Biol (Mosk). 2021 Jan-Feb;55(1):42-53. doi: 10.31857/S0026898421010158.

DNA Damage-Induced Neurodegeneration in Accelerated Ageing and Alzheimer's Disease

Wang H, Lautrup S, Caponio D, Zhang J, Fang EF.

Int J Mol Sci. 2021 Jun 23;22(13):6748. doi: 10.3390/ijms22136748.

Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials

Magham SV, Thaggikuppe Krishnamurthy P, Shaji N, Mani L, Balasubramanian S.

J Neurosci Res. 2021 Nov;99(11):2888-2905. doi: 10.1002/jnr.24933. Epub 2021 Sep 6.

Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease

Lane DJR, Metselaar B, Greenough M, Bush AI, Ayton SJ.

Essays Biochem. 2021 Dec 22;65(7):925-940. doi: 10.1042/EBC20210017.

REM sleep behaviour disorder in patients without synucleinopathy

Keir LHM, Breen DP.

J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1239-1240. doi: 10.1136/jnnp-2020-323475. Epub 2020 Aug 13.

Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)

Richards K, Morrison J, Wang YY, Rangel A, Loera A, Hanlon A, Lozano A, Kovach C, Gooneratne N, Fry L, Allen R.

Res Gerontol Nurs. 2020 Nov 1;13(6):280-288. doi: 10.3928/19404921-20200918-01. Epub 2020 Sep 24.

Effects of Myricitrin and Relevant Molecular Mechanisms

Zhang X, Zhang K, Wang Y, Ma R.

Curr Stem Cell Res Ther. 2020;15(1):11-17. doi: 10.2174/1574888X14666181126103338.

Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis

Fathy YY, Hoogers SE, Berendse HW, van der Werf YD, Visser PJ, de Jong FJ, van de Berg WDJ.

Brain Imaging Behav. 2020 Dec;14(6):2799-2816. doi: 10.1007/s11682-019-00099-3.

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT; AETIONOMY study group.

Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.

Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool

Ha ZY, Mathew S, Yeong KY.

Curr Protein Pept Sci. 2020;21(1):99-109. doi: 10.2174/1389203720666191107094949.

Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer's disease

Isaev NK, Stelmashook EV, Genrikhs EE.

Rev Neurosci. 2020 Apr 28;31(3):233-243. doi: 10.1515/revneuro-2019-0052.

Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy

Lee JY, Jin HK, Bae JS.

BMB Rep. 2020 Jan;53(1):28-34. doi: 10.5483/BMBRep.2020.53.1.278.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias